Jolkinolide B induces neuroendocrine differentiation of human prostate LNCaP cancer cell line
Authors:
- W.K. LiuWLW.K. Liu
- J.C.K. HoJHJ.C.K. Ho
- Guowei QinGQGuowei Qin
- Chun-Tao CheCCChun-Tao Che
- 1 March 2002
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 63 (5) , 951-957
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Activated 3′,5′-Cyclic AMP-dependent Protein Kinase Is Sufficient to Induce Neuroendocrine-like Differentiation of the LNCaP Prostate Tumor Cell LineJournal of Biological Chemistry, 2000
- Diterpenes and aromatic compounds from Euphorbia fischerianaPhytochemistry, 1999
- Valproic acid for the treatment of pediatric malignant gliomaKlinische Padiatrie, 1999
- Regulation of Growth and Prostatic Marker Expression by Activin A in an Androgen-Sensitive Prostate Cancer Cell Line LNCAPBiochemical and Biophysical Research Communications, 1997
- 1,25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Act Synergistically to Inhibit the Growth of LNCaP Prostate Cells and Cause Accumulation of Cells in G1*Endocrinology, 1997
- Diterpenoids from Euphorbia fischerianaPhytochemistry, 1997
- 1,25-dihydroxy-16-ene-23-yne-vitamin d3 and prostate cancer cell proliferation in vivoUrology, 1995
- A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemiaJournal of Immunological Methods, 1994
- Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.Proceedings of the National Academy of Sciences, 1994
- Allose gallates from Euphorbia fischerianaPhytochemistry, 1991